Replies to post #12756 on Moderna Inc (MRNA)

[axelvento]

Moderna is on track to become a multi-product company, and that means it's likely to have many revenue sources down the road.

The company's goal is to capture as much as half of the $30 billion respiratory vaccines market in 2027